AreteiaTx
Tom Denwood is a seasoned executive specializing in digital health and technology, currently serving as Chief Digital Officer at Metsera and Chief Information Officer at AreteiaTx, where initiatives focus on obesity management and asthma treatments, respectively. Denwood holds further responsibilities as Chief Digital Officer at Population Health Partners, leading investments in digital health solutions and pivotal trial technologies. Previously, Denwood held various senior leadership roles at NHS Digital and NHS Connecting for Health, overseeing significant data management projects and IT program recoveries. Educational qualifications include degrees in Biological Sciences from the University of Birmingham and MSc in Major Programme Management from the Saïd Business School, University of Oxford.
This person is not in any offices
AreteiaTx
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication ofimproving lung function and is found in several asthma-related treatments.